News
BIG’s Annual Report 2017 now available
Brussels, Belgium – 27 June 2018. BIG is pleased to present the latest Annual Report 2017. Thanks to your support and the continuous dedi
OUTCOME BIG’S EXECUTIVE BOARD ELECTIONS
Following BIG’s General Assembly (GA), we are very happy to announce the outcome of the BIG Executive Board (EB) elections.
234 patients enrolled in BIG Time for Baby study
BIG Time for Baby makes progress: already 234 women have enrolled in the study with more than 21 healthy babies born.
FONDATION ARC LÉOPOLD GRIFFUEL AWARD FOR TRANSLATIONAL AND CLINICAL RESEARCH
"The prize is a wonderful recognition for the dedication and work of our teams at BIG and at the Jules Bordet Institute" says Prof. Piccart.
1 OUT OF 3 MEN WITH BREAST CANCER DOES NOT RECEIVE ADEQUATE TREATMENT
Researchers confirm the poor quality of care for men affected by breast cancer and urge for a clinical trial.
BIG’s Annual Report 2016 now available
We are pleased to present our latest Annual Report and are very proud of the continuous dedication and hard work of BIG’s now 59 collabora
HERA trial: 11-year follow-up results published in The Lancet
Further to the main trial results that were presented and published in 2005, the final analysis of the HERA study was recently published in
BIG time for baby: 100+ patients enrolled
The international and purely academic POSITIVE study has already recruited more than 100 patients from 113 activated hospitals and cancer ce
Dr. M. Piccart to receive the “2017 St. Gallen International Breast Cancer Award”
Foundation SONK is honouring Professor Martine Piccart for her extraordinary clinical research contribution in the advancement of early, cur
Dr. Giuseppe Curigliano to receive the first ESO Umberto Veronesi Memorial Award
Dr. Curigliano, a member of BIG, received the “ESO Umberto Veronesi Memorial Award” during 15th St. Gallen International Breast Cancer C
Pharmacoeconomics: can we afford new drugs for breast cancer?
The 4th issue of BIG Research in Focus highlights some challenges and questions raised by the ever-increasing cost of new breast cancer drug
MINDACT Trial - 46% of patients could be spared from unnecessary chemotherapy
The first results of the MINDACT trial, using the MammaPrint® test, have just been presented and give hope to many women with early-stage b
Pfizer Awards Breast International Group (BIG) $1 Million Research Grant to Support Non-Drug Related Breast Cancer Research
BIG has received a $1 million educational grant from Pfizer Inc. to support academic research in the field of breast cancer.
Cancer Trials Ireland - Together, we're finding answers to cancer
To co-coincide with International Clinical Trials Day (20 May 2016), Cancer Trials Ireland (formerly known as the All-Ireland Cooperative On